The European Union (EU) has signed a deal with Danish manufacturer Bavarian Nordic for the purchase of 109,090 doses of vaccine to curb the spread of monkeypox.
European Commissioner for Health Stella Kyriakides said that the vaccines will be donated to EU member states, Norway, and Iceland. The first deliveries were scheduled for the end of June.
Thanks to recent orders, Bavarian Nordic has raised its financial expectations for 2022 from between 1,800 and 2,000 million Danish kroner ($252 and $280 million) to between 1,900 and 2,100 million Danish kroner ($266 and $294 million).
There are currently about 900 monkeypox cases in the EU, distributed across 20 countries.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app